Cervix Cancer clinical trials

Explore recruiting cervix cancer clinical trials.

Recruiting cervix cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cervix Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE high risk study initiative

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Cervix Cancer trials by city

Cervix Cancer in Toronto Cervix Cancer in Vancouver Cervix Cancer in Montreal Cervix Cancer in Calgary Cervix Cancer in Edmonton Cervix Cancer in Ottawa Cervix Cancer in Winnipeg Cervix Cancer in Quebec City Cervix Cancer in Hamilton Cervix Cancer in Kitchener Cervix Cancer in London Cervix Cancer in Halifax Cervix Cancer in New York Cervix Cancer in Los Angeles Cervix Cancer in Chicago Cervix Cancer in Houston

Cervix Cancer clinical trials

Recruiting cervix cancer studies right now

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Toripalimab Combined With Definitive CCRT for LACC Patients

A Study of VET3-TGI in Patients With Solid Tumors

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

A Study of NX-1607 in Adults With Advanced Malignancies

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer

Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy

Also recruiting in Europe

A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE high risk study initiative

Cervix Cancer trials by city

Other conditions